Breaking News

Breaking news filtered in real-time to show only the most impactful headlines for US-listed public companies.

While adjusting our outlook to reflect market uncertainty, we stay committed to investing for long-term value creation

Report on first half of 2025 for ROCKWOOL A/S Release no. 50 – 2025 to Nasdaq Copenhagen

How does ROCKWOOL's guidance for H2 2025 compare to peers in the building materials sector, and what are the implications for market share and competitive positioning? What specific market uncertainties are driving the outlook adjustment and how might they impact demand for ROCKWOOL's products? How does the revised outlook affect our valuation metrics and price targets for ROCKWOOL?
Symbol: ROCK
Earnings
22 days ago
Read more globenewswire

PrimeEnergy Resources Corporation Reports Second Quarter and First Half 2025 Results

HOUSTON, Aug. 20, 2025 (GLOBE NEWSWIRE) -- PrimeEnergy Resources Corporation (NASDAQ: PNRG) today announced financial results for the second quarter and first half of 2025. While year-over-year ...

How does PrimeEnergy’s Permian Basin development progress compare to its peers, and what implications does it have for future growth and market share? What is the outlook for cash‑flow generation and capital returns to shareholders given the current oil price environment? How will the decline in year‑over‑year revenue and earnings due to lower oil prices affect PNRG’s valuation and price target?
Symbol: PNRG
Earnings
22 days ago
Read more globenewswire

Silver Miners Enter Parabolic Phase as Analysts Eye $40 Breakout

Issued on behalf of Magma Silver Corp. USA News Group News Commentary VANCOUVER, BC, Aug. 20, 2025 /PRNewswire/ -- Silver miners are early in a parabolic move higher as the precious metal pushes to...

How does the current industrial demand surge compare to historical demand cycles for silver and its impact on mining margins? What is the expected timeline for the parabolic move higher and what catalysts could accelerate or delay it? How will the projected $40 silver price breakout affect MAGS's stock valuation in the short term?
Symbol: MAGS
Mining
22 days ago
Read more prnewswire

Noble Capital Markets Initiates Equity Research Coverage on Greenwich LifeSciences

STAFFORD, Texas, Aug. 20, 2025 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial,...

What is Noble Capital Markets' track record and credibility in recommending clinical‑stage biopharma stocks, and how does this influence investor sentiment? How might the Phase III FLAMINGO‑01 trial timeline and potential outcomes affect GLSI's short‑term price volatility and liquidity? What are the key investment theses and valuation implications from Noble Capital's initiation coverage on GLSI?
Symbol: GLSI
Clinical trials
22 days ago
Read more globenewswire

Energy Vault, Turkey’s Astor Enerji Launch Global Strategic Partnership with BESS Deployments Totalling 2 GWh and 1 GW Transformer Procurement from Astor Enerji

WESTLAKE VILLAGE, Calif. & ISTANBUL--(BUSINESS WIRE)---- $NRGV--Energy Vault Holdings, Inc. (NYSE: NRGV), a global leader in grid-scale energy storage solutions, and Astor Enerji (BIST: ASTOR), a l...

How does this strategic partnership position Energy Vault relative to other energy‑storage players and could it lead to a competitive advantage in the sector? What is the expected timeline for the BESS projects and how might it influence the stock's short‑term price movement? How will the 2 GWh BESS deployment and 1 GW transformer procurement affect Energy Vault's revenue and earnings forecasts?
Symbol: NRGV
Partnership
22 days ago
Read more businesswire

PharmaCyte Biotech, Inc. Announces Closing of $7 Million Financing

LAS VEGAS--(BUSINESS WIRE)--PharmaCyte Biotech, Inc. (Nasdaq:PMCB) (“PharmaCyte” or the “Company”), today announced the closing of its previously announced $7 million financing. As of April 30, 202...

How does PharmaCyte's cash position and financing compare to peers in the biotech sector, and what does it suggest about its ability to fund R&D and potential dilution risk? What specific milestones or timelines does PharmaCyte have for deploying these funds, and how might they impact upcoming earnings or product milestones? How will the $7 million financing and strengthened balance sheet affect PMCB's valuation and price targets?
Symbol: PMCB
Financing
22 days ago
Read more businesswire